PA
DNOW icon

PharVision Advisers’s DNOW Inc DNOW Stock Holding History

PharVision Advisers’s Portfolio DNOW Stock Details DNOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,779
Closed -$342K – 257
2025
Q4 		$342K Buy
+25,779
New +$362K 0.17% 205
2025
Q1 		– Sell
-21,459
Closed -$279K – 332
2024
Q4 		$279K Buy
+21,459
New +$289K 0.24% 181

Other funds holding DNOW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

PharVision Advisers's DNOW Position: Q1 2026 in Review

PharVision Advisers sold out of DNOW Inc (DNOW) in Q1 2026, closing a stake of 25,779 shares — an estimated $342K sold.

PharVision Advisers first reported a position in DNOW in Q4 2024 and held it in 2 quarters. The position peaked at $342K in Q4 2025. 316 funds tracked by Wall St. Rank hold DNOW as of Q1 2026.

  • PharVision Advisers reported no remaining DNOW Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 25,779 DNOW Inc shares in Q1 2026, an estimated $342K.
  • PharVision Advisers first reported a position in DNOW Inc in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's DNOW Inc position peaked at $342K in Q4 2025.
  • 316 funds tracked by Wall St. Rank held DNOW Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.